Dr. Axel Imhof is a professor for protein analytics at the Biomedical Center of the Ludwig-Maximilians University of Munich (LMU) and the director of the Proteomics Core Facility of LMUs Biomedical Center. His lab is among the world leading groups for the characterization of chromatin bound proteins and the characterization of histone modifications using mass spectrometry. He is also the Cofounder of EpiQMAx, a company dedicated to the quantitative analysis of histone modifications in clinical samples. Dr. Imhof has been a member of several national and international clusters of excellence and acts as academic editor for several scientific journals. He is a Co-speaker of the Core Facilities group of the German Society of Mass Spectrometry and an elected member of the European Molecular Biology Organization (EMBO).